查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1197543

医用管材市场 - COVID-19 的增长、趋势、影响和预测 (2023-2028)

Medical Tubing Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 110 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在研究期间（2022-2027 年），医用管材市场预计将以 8.5% 的复合年增长率增长。

最近，各国都面临着 COVID-19 的巨大威胁。 由于供应链中断和住院人数增加，医用管材市场增长受到 COVID-19 的严重影响。 2020 年 4 月发表的一篇文章“严重供应短缺——COVID-19 大流行期间对呼吸机和个人防护设备的需求”指出，与 COVID-19 相关的并发症迅速增加，导致死亡，导致指出对船隻的需求将会增加。 因此，对呼吸机的需求增加也导致对呼吸机管的需求激增，从而推动了市场的增长。 然而，由于 COVID-19 导致的关闭、劳动力短缺、塑料和橡胶等原材料的产量减少以及原材料价格飙升对医用管材的生产产生了重大影响，给市场增长带来了压力。

所研究的市场增长驱动因素包括慢性病和人口老龄化负担的增加、对微创医疗程序的需求增加以及对一次性管状医疗设备的需求增加。 此外，主要市场参与者的新产品发布和战略举措将进一步推动市场增长。

根据 2022 年 1 月发表的文章“未来微创手术的微电子导管”，导管是一种微创手术，可轻鬆去除血块、植入植入物或靶向输送药物。它具有重要意义手术的重要性，旨在对患者特别友好。 这种导管的优势将增加它们的需求，预计在研究期间需求会增加，从而推动研究市场。

此外，产品发布、合併、收购和合作伙伴关係等战略举措也将带来利润丰厚的市场增长。 例如，2021 年 4 月，BioCardia, Inc. 与日本领先的生物技术公司之一就其 BioCardia Helix 导管生物治疗递送产品候选产品达成协议。 这是 BioCardia Helix 导管生物治疗师交付的候选产品的特定细胞类型的心臟适应症的非排他性全球许可。 根据协议，BioCardia 将获得 500,000 美元用于生物治疗药物递送产品和支持服务。

此外，2021 年 6 月，Zeus Industrial Products 宣布收购 CathX Medical Inc.，这是一家医疗设备合同製造公司，为客户提供导管设计工程服务、快速原型製作、製造、完整或子组装的单一来源. 获得了 . 此次收购扩大了 Zeus 的产品组合和地理范围，推动了市场增长。 同样在 2022 年 2 月，Zeus Industrial Products 在其专为可操纵导管设计的产品组合中推出了 PTFE Sub-Lite-Wall 多腔管。

因此，由于上述因素，该研究涵盖的市场预计在研究期间将显着增长。 然而，产品开发的巨大投资和时间预计将阻碍研究期间的市场增长。

医用管材市场趋势

预计在预测期内，导管和插管部分将占据很大的市场份额

导管是一根塑料管，可插入已有开口的区域，例如膀胱或开放性伤口，用于帮助引流液体。 另一方面，插管是一根小塑料管，借助针刺穿静脉或血管，将其插入身体的一部分。 然后取出针头，将插管留在原位，以便于取出或向血管中註入任何东西。

外周动脉疾病、慢性肾病等慢性病负担的增加、老年人口的增加、产品发布的增加以及所研究细分市场参与者的其他战略举措可能会带来利润丰厚的市场增长。

例如，根据 2021 年 6 月发表的研究论文《外周动脉疾病和多血管疾病的流行病学》，美国外周动脉疾病的患病率估计约为 7%，据信有 850 万成年人影响 因此，PAD的高负担有望增加早期治疗的需求并影响医用管材的需求。

此外，该细分市场中产品的推出预计将对市场增长做出重大贡献。 例如，2021 年 4 月，DORC 推出了 EVA AVETA 套管针系统，该系统集成了推入配合注射连接和激光蚀刻保持功能。 这为外科医生和患者带来了好处，例如流量增加、工作尺寸减小和术中眼压稳定。

此外，2021 年 7 月，美敦力公司将在获得 CE 标誌后在欧洲推出 Prevail 药物涂层球囊 (DCB) 导管。 Prevail DCB 在经皮冠状动脉介入治疗 (PCI) 过程中用于治疗冠状动脉疾病 (CAD) 患者狭窄或阻塞的冠状动脉。

因此，由于上述因素，研究部门有望为市场的显着增长做出贡献。

北美将占据很大的市场份额，预计在预测期内也会如此

北美医用导管市场增长的主要驱动力是慢性病和老年人口的增加、产品发布的增加、对微创手术的需求增加以及主要市场参与者的战略举措不断增加。

在研究期间，预计北美地区的美国将占据调查市场的很大份额。 例如，根据美国 2022 年 7 月肾臟疾病统计更新，慢性肾臟疾病 (CKD) 影响美国超过七分之一的成年人，而该国患有肾臟疾病的美国人估计有 3700 万。 国内 CKD 负担的加重将增加对导尿管的需求并推动市场。

此外，同一市场的产品上市和获批也将提振市场。 例如，2021 年 8 月，Argon Medical Devices, Inc. 在美国宣布推出 SKATER Mini-Loop Drainage Catheters，这是一种图像引导并穿过皮肤放置的微创方法，用于去除或排出不需要的液体池。现在发售中。

2021 年 11 月，The Flume Catheter Company Ltd.（以下简称 The Flume. Ltd. (TFCC)）获得美国食品和药物管理局 (FDA) 的批准，可以在美国销售 FLUME 导管。

2022 年 3 月，Shockwave Medical 推出了 Shockwave M5+ 外周 IVL 导管，并获得美国食品药品监督管理局 (FDA) 的批准。 Shockwave M5+ 导管专门设计用于减少血管内碎石术 (IVL) 治疗时间，提供替代通路选择，并将 IVL 治疗扩展至血管尺寸较大的患者。

此外，併购和开设媒体网站等战略举措有助于提高现有产品的知名度和扩大市场，对市场的增长做出了重大贡献。

因此，由于上述因素，所研究的市场有望带来北美市场的有利可图的增长。

医用导管市场竞争者分析

医用管材市场竞争激烈。 主要市场参与者采用的併购和合作伙伴关係等战略举措将推动市场增长。 市场上的主要参与者有 Saint-Gobain、Freudenberg Medical、W. L. Gore & Associates, Inc.、The Lubrizol Corporation、Raumedic AG 等。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动因素
    • 慢性病和人口老龄化负担加重
    • 对微创医疗程序的需求不断增长
    • 对一次性管状医疗器械的需求增加
  • 市场製约因素
    • 产品开发需要大量投资和时间
  • 五力分析分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模 - 百万美元）

  • 按材料
    • 塑料
    • 橡胶
    • 特种聚合物
  • 通过使用
    • 散装一次性试管
    • 给药系统
    • 导管/插管
    • 其他（蠕动泵管、供气管、排烟管）
  • 按结构
    • 单腔
    • 共挤
    • 多流明
    • 编织管
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • Saint-Gobain
    • Freudenberg Medical
    • W. L. Gore & Associates, Inc.
    • The Lubrizol Corporation
    • Raumedic AG
    • Nordson Corporation
    • MDC Industries
    • ZARYS International Group
    • Hitachi, Ltd.
    • NewAge Industries
    • TE Connectivity
    • Optinova

第7章 市场机会今后动向

简介目录
Product Code: 90513

The Medical Tubing Market is Expected to witness a CAGR of 8.5% during the study period (2022-2027).

In recent times, countries have faced a huge threat of COVID-19. The medical tubing market growth was significantly impacted by COVID-19 owing to supply chain disruptions and an increase in hospital admissions. The article "Critical Supply Shortages - The Need for Ventilators and Personal Protective Equipment during the COVID-19 Pandemic," published in April 2020, indicated that there was an increase in demand for ventilators as the complications associated with COVID-19 were surging and leading to mortality. Therefore, this increase in ventilator demand also surged the demand for ventilator tubing, which has driven the market growth. However, the production of medical tubes was severely impacted due to COVID-19-induced lockdown, labor shortage, decrease in the production of raw materials such as plastics and rubbers, the surge in prices of raw materials, and others that were a burden on the market growth.

The factors propelling the studied market growth are the growing burden of chronic diseases and the geriatric population, rising demand for minimally invasive medical procedures, and increasing demand for disposable tube-based medical devices. In addition, new product launches and strategic initiatives taken by the key market players will further drive the market growth.

As per the article "Microelectronic Catheter for Minimally Invasive Surgery of the Future," published in January 2022, catheters are significantly important for minimally invasive surgery due to easily procedures for the removal of blood clots, the insertion of implants, or the targeted administration of drugs, and are intended to be particularly gentle for patients. Such advantages of catheters increase their demand and are expected to increase during the study period, which will boost the studied market.

Additionally, strategic initiatives such as product launches, mergers, and acquisitions, partnerships, and others will also lead to lucrative growth of the market. For instance, in April 2021, BioCardia, Inc. entered into an agreement with one of the leading Japanese biotechnology companies related to BioCardia Helix catheter biotherapeutic delivery product candidates. It is a non-exclusive, worldwide license to BioCardia Helix catheter biotherapeutic delivery product candidates for certain cell types for cardiac indications. Under the terms of the agreement, BioCardia will receive USD 500,000 for biotherapeutic delivery products and support services.

Furthermore, in June 2021, Zeus Industrial Products, Inc. acquired CathX Medical Inc., a medical device contract manufacturer that offers customers a single source for catheter design engineering services, rapid prototyping, manufacturing, and full or sub-assemblies. Such acquisition will expand the product offerings of Zeus and its geographical footprints, which will drive market growth. Also, In February 2022, Zeus Industrial Products launched its PTFE Sub-Lite-Wall multi-lumen tubing to its product portfolio designed for steerable catheters.

Therefore, owing to the aforementioned factors, the studied market is expected to grow significantly during the study period. However, huge investments and time required for product development are expected to hinder the market growth during the study period.

Medical Tubing Market Trends

Catheters and Cannulas Segment is Expected to Account for the Large Market Share During the Forecast Period

A catheter is a plastic tube that is inserted into an area of the body that already has an opening, such as the bladder or an open wound that need needs assistance in draining. However, a cannula is a small plastic tubing that is inserted into part of the body with the help of a needle that punctures the vein or vessel. The needle is then removed, leaving the cannula in place for easy access to withdraw or inject anything into the vessel.

The growing burden of chronic diseases such as peripheral artery diseases, chronic kidney diseases, and others, the growing geriatric population, increase in product launches, and other strategic initiatives by players in the studied segment will lead to lucrative growth of the market.

For instance, according to the research article "Epidemiology of Peripheral Artery Disease and Polyvascular Disease," published in June 2021, the prevalence of peripheral artery disease in the United States is estimated to be approximately 7%, affecting 8.5 million adults. Thus, the high burden of PAD is expected to increase the demand for early treatment, impacting the demand for medical tubing.

Additionally, product launches in the segment will contribute significantly to the market growth. For instance, in April 2021, DORC launched the EVA AVETA trocar cannula system, which integrates a push-fit infusion connection and a laser-etched retention feature. This will benefit surgeons and patients through improved flow rates, a smaller working size, and more stable intra-operative intraocular pressure.

Furthermore, in July 2021, Medtronic plc launched Prevail drug-coated balloon (DCB) Catheter in Europe following the CE mark. The Prevail DCB is used during percutaneous coronary intervention (PCI) procedures to treat narrowed or blocked coronary arteries in patients with coronary artery disease (CAD).

Thus, due to the above-mentioned factors, the studied segment is expected to contribute to the significant growth of the market.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

The primary driving factors for the growth of the North American medical tubing market are the increasing prevalence of chronic diseases and the geriatric population, increasing product launches, increasing demand for minimally invasive procedures, and rising strategic initiatives by key market players.

The United States within North America is expected to hold a significant share of the studied market during the study period. For instance, According to the Kidney Disease Statistics updated in July 2022 for the United States, Chronic kidney disease (CKD) affects more than 1 in 7 United States adults, and it is estimated that 37 million Americans suffer from kidney disease in this country. The growing burden of CKD in the country will increase the demand for urinary catheters, thereby driving the market.

Moreover, product launches and approvals in the market will also boost the market. For instance, in August 2021, Argon Medical Devices, Inc. launched SKATER Mini-Loop Drainage Catheters in the United States, which will be placed through the skin using imaging guidance as a minimally invasive way to remove or drain an unwanted fluid collection.

In November 2021, The Flume Catheter Company Ltd. (TFCC), a medical device company dedicated to developing an improved alternative to the Foley indwelling urinary catheter, received clearance from the United States Food and Drug Administration (FDA) to market the FLUME catheter in the United States.

In March 2022, Shockwave Medical, Inc. launched Shockwave M5+ peripheral IVL catheter after receiving United States Food and Drug Administration (FDA) clearance. The Shockwave M5+ catheter is specifically designed to decrease Intravascular Lithotripsy (IVL) treatment time, provide alternative access options, and expand IVL therapy to patients with larger vessel sizes.

Additionally, strategic initiatives such as mergers and acquisitions, the establishment of media sites, and others by the key market players will help them in creating awareness about their existing products and expanding their reach, thus, contributing to the market growth significantly.

Therefore, due to the above-mentioned factors, the studied market is expected to lead to lucrative growth of the market in North America.

Medical Tubing Market Competitor Analysis

The medical tubing market is moderately competitive. The market growth is boosted by strategic initiatives such as mergers and acquisitions and partnerships adopted by the key market players. The major players in the market are Saint-Gobain, Freudenberg Medical, W. L. Gore & Associates, Inc., The Lubrizol Corporation, Raumedic AG, and others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Burden of Chronic Diseases and Geriatric Population
    • 4.2.2 Rising Demand for Minimally Invasive Medical Procedures
    • 4.2.3 Increasing Demand of Disposable Tube Based Medical Devices
  • 4.3 Market Restraints
    • 4.3.1 Huge Investments and Time Required for Product Development
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 By Material
    • 5.1.1 Plastics
    • 5.1.2 Rubbers
    • 5.1.3 Specialty Polymers
  • 5.2 By Application
    • 5.2.1 Bulk Disposable Tubing
    • 5.2.2 Drug Delivery Systems
    • 5.2.3 Catheters and Cannulas
    • 5.2.4 Others (Peristaltic Pump Tubing, Gas Supply Tubing and Smoke Evacuation Tubing)
  • 5.3 By Structure
    • 5.3.1 Single Lumen
    • 5.3.2 Co-Extruded
    • 5.3.3 Multi Lumen
    • 5.3.4 Braided Tubing
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Saint-Gobain
    • 6.1.2 Freudenberg Medical
    • 6.1.3 W. L. Gore & Associates, Inc.
    • 6.1.4 The Lubrizol Corporation
    • 6.1.5 Raumedic AG
    • 6.1.6 Nordson Corporation
    • 6.1.7 MDC Industries
    • 6.1.8 ZARYS International Group
    • 6.1.9 Hitachi, Ltd.
    • 6.1.10 NewAge Industries
    • 6.1.11 TE Connectivity
    • 6.1.12 Optinova

7 MARKET OPPORTUNITIES AND FUTURE TRENDS